Compare Clinical Characteristics of Psittacosis Pneumonia in 35 Patients and of Non Psittacosis Bacterial Pneumonia in 46 Patients
Infection and Drug Resistance · 2024-07 · Volume 17 · 2913-2921
DOI: 10.2147/idr.s453900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2024-07. Verfasst von Jiamei Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hunan Medical College General Hospital, Huaihua, Hunan Province, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
We aimed to describe the difference between Chlamydia psittaci pneumonia group and non C. psittaci bacterial pneumonia group in community acquired pneumonia in this single-center clinical study.
Methods
We collected the data of 35 patients with C. psittaci pneumonia cases and 46 patients with non C. psittaci bacterial pneumonia cases diagnosed with metagenomic next-generation sequencing assays from February 2019 to December 2021 in Huaihua First People's Hospital in China.
Results
In the C. psittaci pneumonia group, 35 patients (100%) had a chance of exposure to poultry or birds, and their body temperature was greater than or equal to 39.0°C. The other common symptoms were a slow pulse (68.6%), cough (65.7%), expectoration (54.3%), chills (51.4%) and a shortness of breath (37.1%). Laboratory tests showed that >90% of the cases had markedly elevated infection indicators, and 97.1% of the cases had markedly declined calcium. The most common imaging finding was patchy shadows (94.3%), pleural effusion (68.6%), bilateral in 54.3% (n = 19) and unilateral in 45.7% (n = 16) participants, and 51.4% (n = 18) of cases met the criteria for severe pneumonia. In the non C. psittaci bacterial pneumonia group, 18 patients (39.1%) had a chance of exposure to poultry or birds, and 11 patients (23.9%) body temperature was greater than or equal to 39.0°C. Laboratory tests showed that >67% of cases had a mildly elevated infection indicators, and mildly declined serum albumin.
Conclusion
The following characteristics are more likely to help distinguish C. psittaci pneumonia from non C. psittaci bacterial pneumonia. Including had a chance of exposure to poultry or birds, high fever, exhibit chills, expectoration, relatively slow pulse, and progress into severe pneumonia. Percentage of neutrophils, C-reactive protein, procalcitonin, lactate dehydrogenase, and myoglobin levels are higher. Blood calcium and corrected calcium are lower. Chest CT showed pleural effusion, pericardial effusion, and mediastinal lymphadenopathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hunan Medical College General Hospital, Huaihua, Hunan Province, People's Republic of China.
- Department of Clinical Pharmacy Group, Hunan Medical College General Hospital, Huaihua, Hunan Province, People's Republic of China.
- Department of Intensive Care Medicine, Hunan Medical College General Hospital, Huaihua, Hunan Province, People's Republic of China.
Zitieren
APA
Chen, J., Wang, J., Deng, Z., Li, Y., & Zhou, J. (2024). Compare Clinical Characteristics of Psittacosis Pneumonia in 35 Patients and of Non Psittacosis Bacterial Pneumonia in 46 Patients. Infection and Drug Resistance, Volume 17, 2913-2921. https://doi.org/10.2147/idr.s453900
Vancouver
Chen J, Wang J, Deng Z, Li Y, Zhou J. Compare Clinical Characteristics of Psittacosis Pneumonia in 35 Patients and of Non Psittacosis Bacterial Pneumonia in 46 Patients. Infection and Drug Resistance. 2024;Volume 17:2913-2921. doi:10.2147/idr.s453900
BibTeX
@article{Chen2024,
author = {Chen, Jiamei and Wang, Jin and Deng, Ziwei and Li, Yongzhong and Zhou, Jianliang},
title = {Compare Clinical Characteristics of Psittacosis Pneumonia in 35 Patients and of Non Psittacosis Bacterial Pneumonia in 46 Patients},
journal = {Infection and Drug Resistance},
year = {2024},
volume = {Volume 17},
pages = {2913--2921},
doi = {10.2147/idr.s453900}
}
EUVIMED